The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin.
Open accessAbstract
Hepcidin is encoded as an 84 amino acid prepropeptide containing a typical N-terminal 24 amino acid endoplasmic reticulum targeting signal sequence, and a 35 amino acid proregion (pro) with a consensus furin cleavage site immediately followed by the C-terminal 25 amino acid bioactive iron-regulatory hormone (mature peptide). We performed pulse-chase studies of posttranslational processing of hepcidin in human hepatoma HepG2 cells and in primary human hepatocytes induced with bone morphogenic protein (BMP-9). In some experiments, the cells were treated with the furin protease inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone (CMK) or furin siRNA. In the absence of furin inhibitor, hepcidin was found to be processed in less than 1 h and secreted as a 3 kDa form reactive with anti-mature but not anti-pro antibody. In the presence of furin inhibitors or furin siRNA, a 6 kDa form reactive with both anti-pro and anti-mature antibody was rapidly secreted into the medium. Processing was not affected by inhibitors of the hypoxia inducible factor (HIF) pathway, or by treatment with 30 microM holo- or apo-transferrin. In conclusion, the hepatic prohormone convertase furin mediates the posttranslational processing of hepcidin. The proteolytic cleavage of prohepcidin to hepcidin is not regulated by iron-transferrin or the HIF pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Proteolytic processing of the prohormone is carried out by furin in a relatively unregulated manner.98”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [98]
Citations
Cites
Schägger, H., & von Jagow, G. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90587-2 · Cited by 11,420
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Self-citationNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Self-citationHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Self-citationPigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Steiner, D. F. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80033-1 · Cited by 650
Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS
Kemna, E., Pickkers, P., Nemeth, E., van der Hoeven, H., & Swinkels, D. (2005) · Blood · doi:10.1182/blood-2005-03-1159 · Cited by 498
Suppression of hepcidin during anemia requires erythropoietic activity
Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood · doi:10.1182/blood-2006-06-028787 · Cited by 472
Self-citation
Flagged first, then by citations
1 of the 32 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Ganz, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2013 · Cited by 1,122
Self-citationForging a field: the golden age of iron biology.
Andrews, N. C. (2008) · Blood · doi:10.1182/blood-2007-12-077388 · Cited by 623
The Role of Hepcidin in Iron Metabolism
Nemeth, E., & Ganz, T. (2009) · Acta Haematologica · doi:10.1159/000243791 · Cited by 607
Mechanisms of mammalian iron homeostasis
Pantopoulos, K., Porwal, S. K., Tartakoff, A., & Devireddy, L. (2012) · Biochemistry · doi:10.1021/bi300752r · Cited by 598
Silvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J., & Camaschella, C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.012 · Cited by 555
Immunoassay for human serum hepcidin
Ganz, T., Olbina, G., Girelli, D., Nemeth, E., & Westerman, M. (2008) · Blood · doi:10.1182/blood-2008-02-139915 · Cited by 688
Regulation of iron transport and the role of transferrin
Gkouvatsos, K., Papanikolaou, G., & Pantopoulos, K. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.10.013 · Cited by 518
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
Ashby, D. R., Gale, D. P., Busbridge, M., Murphy, K. G., Duncan, N. D., Cairns, T. D. H., Taube, D. H., Bloom, S. R., Tam, F. W. K., Chapman, R., et al. (2009) · Kidney International · doi:10.1038/ki.2009.21 · Cited by 313
An overview of molecular basis of iron metabolism regulation and the associated pathologies
Silva, B., & Faustino, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.03.011 · Cited by 300
A Short Review of Iron Metabolism and Pathophysiology of Iron Disorders
Yiannikourides, A., & Latunde-Dada, G. O. (2019) · Medicines · doi:10.3390/medicines6030085 · Cited by 276
Hepcidin in Human Iron Disorders: Diagnostic Implications
Kroot, J. J., Tjalsma, H., Fleming, R. E., & Swinkels, D. W. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2009.140053 · Cited by 246
Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
Babitt, J. L., & Lin, H. Y.-F. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.030 · Cited by 245
Anderson, E. R., & Shah, Y. M. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120016 · Cited by 262
An essential cell-autonomous role for hepcidin in cardiac iron homeostasis
Lakhal-Littleton, S., Wolna, M., Chung, Y. J., Christian, H. C., Heather, L. C., Brescia, M., Ball, V., Diaz, R., Santos, A., Biggs, D., et al. (2016) · eLife · doi:10.7554/elife.19804 · Cited by 184
The liver: conductor of systemic iron balance
Meynard, D., Babitt, J. L., & Lin, H. Y.-F. (2013) · Blood · doi:10.1182/blood-2013-06-427757 · Cited by 181
Regulation of Hepcidin and Iron-Overload Disease
Lee, P. L., & Beutler, E. (2009) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092205 · Cited by 174
Khalafallah, A. A., & Dennis, A. E. (2012) · Journal of Pregnancy · doi:10.1155/2012/630519 · Cited by 172
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo
Poli, M., Girelli, D., Campostrini, N., Maccarinelli, F., Finazzi, D., Luscieti, S., Nai, A., & Arosio, P. (2011) · Blood · doi:10.1182/blood-2010-06-289082 · Cited by 148
The pathophysiology and pharmacology of hepcidin
Ruchala, P. P., & Nemeth, E. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.01.004 · Cited by 141
Genetics, genetic testing, and management of hemochromatosis: 15 years since hepcidin
Pietrangelo, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.045 · Cited by 136
Viatte, L., & Vaulont, S. (2009) · Biochimie · doi:10.1016/j.biochi.2009.06.012 · Cited by 140
Current approach to hemochromatosis
Brissot, P., Troadec, M., Bardou‐Jacquet, E., Lan, C. L., Jouanolle, A., Deugnier, Y., & Loréal, O. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.03.001 · Cited by 132
Hepcidin antagonists for potential treatments of disorders with hepcidin excess
Poli, M., Asperti, M., Ruzzenenti, P., Regoni, M., & Arosio, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00086 · Cited by 124
Molecular evolution and characterization of hepcidin gene products in vertebrates
Hilton, K. B., & Lambert, L. A. (2008) · Gene · doi:10.1016/j.gene.2008.02.016 · Cited by 122
Hepcidin in human iron disorders: Therapeutic implications
Pietrangelo, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.004 · Cited by 115
Young, M. F., Glahn, R. P., Ariza‐Nieto, M., Inglis, J., Olbina, G., Westerman, M. E., & O'Brien, K. O. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26589 · Cited by 112
Iron homeostasis in breast cancer
Marques, O., da Silva, B. M., Porto, G., & Lopes, C. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.029 · Cited by 116
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload
Barisani, D., Pelucchi, S., Mariani, R., Galimberti, S., Trombini, P., Fumagalli, D., Meneveri, R., Nemeth, E., Ganz, T., & Piperno, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.011 · Cited by 111
Hepcidin Signaling in Health and Disease: Ironing Out the Details
Kowdley, K. V., Gochanour, E. M., Sundaram, V., Shah, R. A., & Handa, P. (2021) · Hepatology Communications · doi:10.1002/hep4.1717 · Cited by 113
Troutt, J. S., Rudling, M., Persson, L., Ståhle, L., Angelin, B., Butterfield, A. M., Schade, A. E., Cao, G., & Konrad, R. J. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.186866 · Cited by 100
Garrick, M. D., & Garrick, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.018 · Cited by 105
Iron metabolism: current facts and future decisions
Tandara, L., & Salamunić, I. (2012) · Biochemia Medica · doi:10.11613/bm.2012.034 · Cited by 102
Gender-related variations in iron metabolism and liver diseases
Harrison-Findik, D. D. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i8.302 · Cited by 105
Ehsani, S. (2020) · Biology Direct · doi:10.1186/s13062-020-00275-2 · Cited by 89
Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias
Nemeth, E. (2009) · Advances in Hematology · doi:10.1155/2010/750643 · Cited by 88
A Novel Immunological Assay for Hepcidin Quantification in Human Serum
Koliaraki, V., Marinou, M., Vassilakopoulos, T. P., Vavourakis, E., Tsochatzis, E. A., Pangalis, G. A., Papatheodoridis, G., Stamoulakatou, A., Swinkels, D. W., Papanikolaou, G. V., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004581 · Cited by 86
Laarakkers, C. M., Wiegerinck, E. T. G., Klaver, S. M., Kolodziejczyk, M., Gille, H., Hohlbaum, A. M., Tjalsma, H., & Swinkels, D. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075518 · Cited by 84
Guillemot, J., Canuel, M., Essalmani, R., Prat, A., & Seidah, N. G. (2013) · Hepatology · doi:10.1002/hep.26297 · Cited by 86
Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies
Taher, A. T., Hershko, C., & Cappellini, M. D. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07848.x · Cited by 81
Genetic mechanisms and modifying factors in hereditary hemochromatosis
Weiss, G. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.201 · Cited by 82
Iron Homeostasis and Its Interaction with Prolyl Hydroxylases
Mole, D. R. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2790 · Cited by 80
Altered Iron Metabolism Is Part of the Choroid Plexus Response to Peripheral Inflammation
Marques, F., Falcão, A. M., Sousa, J. C., Coppola, G., Geschwind, D. H., Sousa, N., Correia‐Neves, M., & Palha, J. A. (2009) · Endocrinology · doi:10.1210/en.2008-1610 · Cited by 86
Poli, M., Luscieti, S., Gandini, V., Maccarinelli, F., Finazzi, D., Silvestri, L., Roetto, A., & Arosio, P. (2010) · Haematologica · doi:10.3324/haematol.2010.027003 · Cited by 81
Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?
Swinkels, D. W., & Wetzels, J. F. M. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn267 · Cited by 79
Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease
Oustamanolakis, P., Κoutroubakis, I. E., Messaritakis, I., Malliaraki, N. E., Sfiridaki, A., & Kouroumalis, E. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328343b885 · Cited by 78
Solstad, T., LARSEN, A., Seppola, M., & JORGENSEN, T. (2008) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2008.05.013 · Cited by 77
The role of hepatic transferrin receptor 2 in the regulation of iron homeostasis in the body
Worthen, C., & Enns, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00034 · Cited by 80
HIF prolyl hydroxylase inhibitors for anemia
Muchnik, E., & Kaplan, J. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.566861 · Cited by 76
Therapeutic potential of hepcidin − the master regulator of iron metabolism
Vyoral, D., & Petrák, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.010 · Cited by 79
The Role of Hepcidin in Iron Homeostasis and Anemia in Hemodialysis Patients
Eleftheriadis, T., Liakopoulos, V., Antoniadi, G., Kartsios, C., & Stefanidis, I. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00532.x · Cited by 66
Iron and hepcidin mediate human colorectal cancer cell growth
Sornjai, W., Long, F. N. V., Pion, N., Pasquer, A., Saurin, J., Marcel, V., Diaz, J., Mertani, H. C., & Smith, D. R. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109021 · Cited by 66
High‐sensitive radioimmunoassay for human serum hepcidin
Grebenchtchikov, N. I., Geurts-Moespot, A. J., Kroot, J. J., den Heijer, M., Tjalsma, H., Swinkels, D. W., & Sweep, F. C. G. J. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07758.x · Cited by 65
Wahedi, M., Wortham, A. M., Kleven, M. D., Zhao, N., Jue, S. F., Enns, C. A., & Zhang, A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.801795 · Cited by 68
Truksa, J., Gelbart, T., Peng, H., Beutler, E., Beutler, B., & Lee, P. L. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07873.x · Cited by 66
Vela, D. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0008-7 · Cited by 65
Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
Hawula, Z. J., Wallace, D. F., Subramaniam, V. N., & Rishi, G. (2019) · Pharmaceuticals · doi:10.3390/ph12040170 · Cited by 62
Iron Pathophysiology in Alzheimer’s Diseases
Wang, T., Xu, S.-F., Fan, Y.-G., Li, L.-B., & Guo, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_5 · Cited by 64
Kumar, R., Ali, S. A., Singh, S. K., Bhushan, V., Mathur, M., Jamwal, S., Mohanty, A. K., Kaushik, J. K., & Kumar, S. (2020) · Veterinary Sciences · doi:10.3390/vetsci7040206 · Cited by 62
Tsochatzis, E. A., Papatheodoridis, G., Koliaraki, V., Hadziyannis, E. S., Kafiri, G., Manesis, E. K., Mamalaki, A., & Archimandritis, A. J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01244.x · Cited by 61
A dual-monoclonal sandwich ELISA specific for hepcidin-25
Butterfield, A. M., Luan, P., Witcher, D. R., Manetta, J., Murphy, A. T., Wroblewski, V. J., & Konrad, R. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.151522 · Cited by 59
Recombinant medaka (Oryzias melastigmus) pro-hepcidin: Multifunctional characterization
Cai, L., Cai, J.-J., Liu, H., Fan, D.-Q., Peng, H., & Wang, K. (2011) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2011.10.006 · Cited by 59
Modulation of hepcidin to treat iron deregulation: potential clinical applications
Blanchette, N. L., Manz, D. H., Torti, F. M., & Torti, S. V. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2016.1124757 · Cited by 59
Tarifeño-Saldivia, E., Aguilar, A., Contreras, D., Mercado, L. A., Lange, B. M., Márquez, K., Henríquez, A., Riquelme-Vidal, C., & Boltaña, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01296 · Cited by 59
Thalassaemia Intermedia: an Update
Taher, A. T., Musallam, K. M., & Cappellini, M. D. (2009) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2009.004 · Cited by 59
Miiuy Croaker Hepcidin Gene and Comparative Analyses Reveal Evidence for Positive Selection
Xu, T., Sun, Y., Shi, G., & Wang, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035449 · Cited by 56
Osman, E. E. A., Rehemtulla, A., & Neamati, N. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00518 · Cited by 54
Factors influencing disease phenotype and penetrance in HFE haemochromatosis
Rochette, J., Gac, G. L., Lassoued, K., Férec, C., & Robson, K. (2010) · Human Genetics · doi:10.1007/s00439-010-0852-1 · Cited by 52
Zeng, L., Pei, L., Li, C. L., & Yan, H. (2018) · InTech eBooks · doi:10.5772/intechopen.69048 · Cited by 50
Varga, E., Pap, R., Jánosa, G., Sipos, K., & Pandur, E. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03322-0 · Cited by 60
Gagliardo, B., Kubat, N. J., Faye, A., Jaouen, M., Durel, B., Deschemin, J., Canonne‐Hergaux, F., Sari, M., & Vaulont, S. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.018 · Cited by 45
Non-HFE hemochromatosis: Pathophysiological and diagnostic aspects
Bardou‐Jacquet, E., Ali, Z. B., Beaumont-Epinette, M.-P., Loréal, O., Jouanolle, A., & Brissot, P. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.11.003 · Cited by 47
Kay, R. G., Challis, B., Casey, R. T., Roberts, G. P., Meek, C. L., Reimann, F. M., & Gribble, F. M. (2018) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.8183 · Cited by 44
Hepcidin and the iron enigma in HCV infection
Georgopoulou, U., Dimitriadis, A., Foka, P., Karamichali, E., & Mamalaki, A. (2014) · Virulence · doi:10.4161/viru.28508 · Cited by 43
Troutt, J. S., Butterfield, A. M., & Konrad, R. J. (2013) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21634 · Cited by 43
Hepcidin, an overview of biochemical and clinical properties
Rauf, A., Shariati, M. A., Khalil, A. A., Bawazeer, S., Heydari, M., Plygun, S., Laishevtcev, A. I., Hussain, M. B., Alhumaydhi, F. A., & Aljohani, A. S. M. (2020) · Steroids · doi:10.1016/j.steroids.2020.108661 · Cited by 40
Pandur, E., Tamási, K., Pap, R., Varga, E., Miseta, A., & Sipos, K. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00694-4 · Cited by 37
Wang, J., Liu, W., Li, J. C., Li, M., Li, B., & Zhu, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.714756 · Cited by 38
Insight onto the Pathophysiology and Clinical Complications of Thalassemia Intermedia
Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2009) · Hemoglobin · doi:10.3109/03630260903351528 · Cited by 38
Neogenin Facilitates the Induction of Hepcidin Expression by Hemojuvelin in the Liver
Zhao, N., Maxson, J. E., Zhang, R. H., Wahedi, M., Enns, C. A., & Zhang, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721191 · Cited by 37
Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human Hepatocytes
Béliveau, F., Tarkar, A., Dion, S. P., Désilets, A., Ghinet, M. G., Boudreault, P., St-Georges, C., Marsault, É., Paone, D. V., Collins, J. L., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.09.004 · Cited by 37
Iron and Hepatic Carcinogenesis
Tirnitz‐Parker, J. E. E., Glanfield, A., Olynyk, J. K., & Ramm, G. A. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013007759 · Cited by 42
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis
Duminuco, A., Chifotides, H. T., Giallongo, S., Giallongo, C., Tibullo, D., & Palumbo, G. A. (2023) · Cancers · doi:10.3390/cancers16010154 · Cited by 39
Serum Hepcidin-20 is Elevated during the Acute Phase of Myocardial Infarction
Suzuki, H., Toba, K., Kato, K., Ozawa, T., Tomosugi, N., Higuchi, M., Kusuyama, T., Iso, Y., Kobayashi, N., Yokoyama, S.-I., et al. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.218.93 · Cited by 38
Production of biologically active forms of recombinant hepcidin, the iron‐regulatory hormone
Gagliardo, B., Faye, A., Jaouen, M., Deschemin, J., Canonne‐Hergaux, F., Vaulont, S., & Sari, M. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06525.x · Cited by 36
Blood Iron Homeostasis: Newly Discovered Proteins and Iron Imbalance
Bleackley, M. R., Wong, A. Y. K., Hudson, D. M., Wu, C., & MacGillivray, R. T. A. (2009) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2008.12.001 · Cited by 38
Detection of the hepcidin prepropeptide and mature peptide in liver of rainbow trout
Álvarez, C., Santana, P., Guzmán, F., Marshall, S. H., & Mercado, L. A. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.04.002 · Cited by 36
Kartikasari, A. E. R., Roelofs, R., Schaeps, R. M. J., Kemna, E., Peters, W. H. M., Swinkels, D. W., & Tjalsma, H. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.08.004 · Cited by 35
Cloning, sequencing and expression analysis of the equine hepcidin gene by real-time PCR
Oliveira-Filho, J. P., Badial, P. R., da Cunha, P. H. J., Cruz, T. F., Araújo, J. P., Divers, T. J., Winand, N. J., & Borges, A. S. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.10.027 · Cited by 35
Scamuffa, N., Basak, A., Lalou, C., Wargnier, A., Marcinkiewicz, J., Siegfried, G., Chrétien, M., Calvo, F. M., Seidah, N. G., & Khatib, A. (2008) · Gut · doi:10.1136/gut.2007.141812 · Cited by 35
Regulation of Iron Absorption in Hemoglobinopathies
Rechavi, G., & Rivella, S. (2008) · Current Molecular Medicine · doi:10.2174/156652408786241401 · Cited by 32
Development of a sandwich ELISA for quantifying hepcidin in Rainbow trout
Santana, P., Álvarez, C., Guzmán, F., & Mercado, L. A. (2013) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2013.06.005 · Cited by 33
Iron and oxygen sensing: a tale of 2 interacting elements?
Simpson, R. J., & McKie, A. T. (2014) · Metallomics · doi:10.1039/c4mt00225c · Cited by 32
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study
Campostrini, N., Traglia, M., Martinelli, N., Corbella, M., Cocca, M., Manna, D., Castagna, A., Masciullo, C., Silvestri, L., Olivieri, O., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.08.006 · Cited by 31
Anderson, D. S., Heeney, M. M., Roth, U., Menzel, C., Fleming, M. D., & Steen, H. (2010) · Analytical Chemistry · doi:10.1021/ac902479p · Cited by 31
α‐1 Antitrypsin binds preprohepcidin intracellularly and prohepcidin in the serum
Pandur, E., Nagy, J., Poór, V. S., Sarnyai, Á., Huszár, A., Miseta, A., & Sipos, K. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06937.x · Cited by 29
Mechanisms and Regulation of Intestinal Iron Transport
Collins, J. F., Flores, S. R., Wang, X., & Anderson, G. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00060-8 · Cited by 30
The interplay between iron and oxygen homeostasis with a particular focus on the heart
Lakhal‐Littleton, S., & Robbins, P. A. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00237.2017 · Cited by 29
20 years of Hepcidin: How far we have come
Colucci, S., Marques, O., & Altamura, S. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.05.001 · Cited by 28
Identification of an iron–hepcidin complex
Farnaud, S., Rapisarda, C., Bui, T. T. T., Drake, A. F., Cammack, R., & Evans, R. W. (2008) · Biochemical Journal · doi:10.1042/bj20080406 · Cited by 29
Gong, L.-C., Wang, H., & Deng, L. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.11.007 · Cited by 28
Metadata
- Authors
- Valore, E. V., & Ganz, T.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Ganz, Tomas
- ORCID
- Ganz, Tomas
- Venue
- Blood Cells Molecules and Diseases
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 40
- Issue
- 1
- Pages
- 132-138
- ISSN
- 1079-9796 (ISSN-L)
- PMC
- PMC2211381
- OpenAlex
- W2054421541
- Cited by
- 234
- References
- 32
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 1 · 2022: 5 · 2021: 11 · 2020: 9 · 2019: 15 · 2018: 14 · 2017: 11 · 2016: 11 · 2015: 9 · 2014: 10 · 2013: 19 · 2012: 15
- FWCI
- 15.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood Cells Molecules and Diseases (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK065029)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Physical Sciences › Materials Science › Metals and Alloys › Iron and Steelmaking Processes
- Keywords
- hepcidin, furin, prohormone convertases, post-translational processing, prohepcidin, hepatocytes, BMP9, iron regulation, hypoxia-inducible factor, transferrin, proteolytic cleavage, HepG2 cells
- MeSH terms
- Humans, Peptide Fragments, Protein Processing, Post-Translational, Transferrin, Hepatocytes, Antimicrobial Cationic Peptides, Proprotein Convertases, Furin, Hypoxia-Inducible Factor 1, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review